ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1454

Quantitative and Qualitative Tracking of Expanded CD4+ T Cell Clones in Rheumatoid Arthritis Patients

Kazuyoshi Ishigaki1, Hirofumi Shoda2, Yuta Kochi3, Tetsurou Yasui4, Yuho Kadono4, Sakae Tanaka4, Keishi Fujio2 and Kazuhiko Yamamoto1, 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Department of Allergy and Rheumatology, The University of Tokyo, Tokyo, Japan, 3Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, 4Department of Orthopaedic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: T cells and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

The purpose of this study is to elucidate the characteristics of expanded CD4+ T cell clones (ECs) in peripheral blood and synovium of rheumatoid arthritis (RA) patients by T cell receptor (TCR) repertoire and single cell transcriptome analysis.

Methods

We obtained peripheral blood from 5 RA patients and 5 control subjects. We performed TCR repertoire analysis by combination of single cell and next-generation sequencer (NGS) in CD4+ T cells. We also performed single cell RNA-Seq and real time PCR analysis of ECs and non-expanded clones (NECs). Similarly, CD4+ T cells from synovium were analyzed in 1 patient.

Results

We detected significantly higher frequency of ECs in peripheral blood of 4 RA patients compared with controls both in naïve and memory subset of CD4+ T cells. Within memory CD4+ T cells of peripheral blood, non-Th1/Th17/Tfh subset (negative for CXCR3, CCR6 and CXCR5) contained majority of expanded clones in PBMC of 3 RA patients and synovium-infiltrating clones in 1 RA patient. Gene expression analysis of the mostly expanded CD4+ T cell clones in synovium of 1 RA patient and peripheral blood of 2 RA patients revealed up-regulation of GZMB, TBX21 and CD5 and down-regulation of CD28 compared with NECs. The tracking of gene expression profile of one unique EC in peripheral blood showed down-regulation of CXCR4 and CCR5 compared with that of the identical clone in synovium of the same patient.

Conclusion

ECs were more frequently observed in non-Th1/Th17/Tfh subset in peripheral blood and had gene expression profiles consistent with senescent CD4+ T cells in both of peripheral blood and synovium. Given that there are no reliable markers of clonal expansion, single cell transcriptome analysis is the only method to investigate gene expression profiles of expanded clones. Combined with the robustness of NGS TCR repertoire analysis, our approach should be a rational strategy to characterize ECs and might be able to identify pathogenic clones in RA.


Disclosure:

K. Ishigaki,
None;

H. Shoda,
None;

Y. Kochi,
None;

T. Yasui,
None;

Y. Kadono,
None;

S. Tanaka,
None;

K. Fujio,
None;

K. Yamamoto,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantitative-and-qualitative-tracking-of-expanded-cd4-t-cell-clones-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology